Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders.
De Luca G, Trasarti S, Bizzoni L, Del Giudice I, Della Starza I, De Propris MS, Gentile G, Mancini F, Mantovani S, Petrucci L, Tabanelli V, Guarini A, Vignetti M, Foà R. De Luca G, et al. Among authors: de propris ms. Leuk Lymphoma. 2018 Nov;59(11):2715-2718. doi: 10.1080/10428194.2018.1439583. Epub 2018 Feb 23. Leuk Lymphoma. 2018. PMID: 29473430 No abstract available.
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy.
Di Rocco A, Cuneo A, Di Rocco A, Merli F, De Luca G, Petrucci L, Ansuinelli M, Penna D, Rotondo F, Rigolin GM, Giaimo M, Re F, Farcomeni A, Martelli M, Foà R. Di Rocco A, et al. Among authors: de luca g. Leuk Lymphoma. 2021 Apr;62(4):828-836. doi: 10.1080/10428194.2020.1849676. Epub 2020 Dec 4. Leuk Lymphoma. 2021. PMID: 33274677
Real-life evaluation of potential candidates for treatment discontinuation in chronic myeloid leukemia: the impact of age and long-term follow-up.
Scalzulli E, Colafigli G, Pepe S, De Luca G, Di Prima A, Efficace F, Diverio D, Latagliata R, Martelli M, Foà R, Breccia M. Scalzulli E, et al. Among authors: de luca g. Leuk Lymphoma. 2021 Apr;62(4):1026-1027. doi: 10.1080/10428194.2020.1808205. Epub 2020 Aug 16. Leuk Lymphoma. 2021. PMID: 32799601 No abstract available.
Direct oral anticoagulants in patients with hematologic malignancies.
Serrao A, Fiori L, Santoro C, De Luca ML, Ferretti A, De Luca G, Ligia S, Lapietra G, Mohamed S, Breccia M, Chistolini A. Serrao A, et al. Among authors: de luca ml, de luca g. Hematol Oncol. 2020 Oct;38(4):589-596. doi: 10.1002/hon.2770. Epub 2020 Jul 29. Hematol Oncol. 2020. PMID: 32588912
Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.
D'Abramo A, Zingaropoli MA, Oliva A, D'Agostino C, Al Moghazi S, De Luca G, Iannetta M, d'Ettorre G, Ciardi MR, Mastroianni CM, Vullo V. D'Abramo A, et al. Among authors: de luca g. PLoS One. 2016 Feb 25;11(2):e0149601. doi: 10.1371/journal.pone.0149601. eCollection 2016. PLoS One. 2016. PMID: 26913505 Free PMC article.
Cost-effectiveness of outpatient adherence to recommendations for monitoring of patients hospitalized for heart failure.
Corrao G, Rea F, Iommi M, Lallo A, Fantaci G, Di Martino M, Davoli M, Leoni O, Pompili M, Scondotto S, De Luca G, Carle F, Lorusso S, Giordani C, Di Lenarda A, Maggioni AP; Monitoring and Assessing care Pathways (MAP)' working group of the Italian Ministry of Health. Corrao G, et al. Among authors: de luca g. ESC Heart Fail. 2024 May 9. doi: 10.1002/ehf2.14779. Online ahead of print. ESC Heart Fail. 2024. PMID: 38725148 Free article.
1,607 results